Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Authors
Keywords
-
Journal
Annals of Hepatology
Volume -, Issue -, Pages 101174
Publisher
Elsevier BV
Online
2023-10-29
DOI
10.1016/j.aohep.2023.101174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic dysfunction: The silenced connection with fatty liver disease
- (2023) Mariana M. Ramírez-Mejía et al. Annals of Hepatology
- The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight/Obese Adults with NAFLD
- (2022) Martina Chiurazzi et al. Nutrients
- Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
- (2022) Jingxuan Quek et al. Lancet Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. International Journal of Surgery
- Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
- (2020) Anton Gillessen et al. ADVANCES IN THERAPY
- Risk of Cirrhosis and Hepatocellular Cancer in Patients with Non‐Alcoholic Fatty Liver Disease and Normal Liver Enzymes
- (2020) Yamini Natarajan et al. HEPATOLOGY
- Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice
- (2020) Erhan Sahin et al. JOURNAL OF FOOD BIOCHEMISTRY
- Effect of aerobic training with silymarin consumption on glycemic indices and liver enzymes in men with type 2 diabetes
- (2020) Keyvan Ghalandari et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Reply to: correspondence regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome
- (2020) Masahiro Sogabe et al. PLoS One
- Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease
- (2020) Ludovico Abenavoli et al. MINERVA MEDICA
- Treatment options for nonalcoholic fatty liver disease
- (2019) Amir Anushiravani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Olive oil antioxidants and non-alcoholic fatty liver disease
- (2019) Ludovico Abenavoli et al. Expert Review of Gastroenterology & Hepatology
- Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
- (2019) Victor J. Navarro et al. PLoS One
- Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial
- (2018) Soraiya Ebrahimpour-koujan et al. PHYTOMEDICINE
- Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents
- (2018) Sheela Deivanayagam et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
- (2017) Federico Salomone et al. Nutrients
- Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization
- (2017) Usama Ahmad et al. Artificial Cells Nanomedicine and Biotechnology
- Changes in liver volume and body composition during 4 weeks of low calorie diet before laparoscopic gastric bypass
- (2015) David Edholm et al. Surgery for Obesity and Related Diseases
- Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease
- (2015) Ludovico Abenavoli et al. Expert Review of Gastroenterology & Hepatology
- Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
- (2015) Pegah Golabi et al. Expert Review of Gastroenterology & Hepatology
- Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
- (2014) Eung Ju Kim et al. PLoS One
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Alterations in Sulfur Amino Acid Metabolism in Mice Treated with Silymarin: A Novel Mechanism of Its Action Involved in Enhancement of the Antioxidant Defense in Liver
- (2013) Do Kwon et al. PLANTA MEDICA
- What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
- (2013) Giovanni Tarantino WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Mohammad Kazem Fallahzadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats
- (2012) Devaraj Ezhilarasan et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- EFFECT OF SILYMARIN ON LIPID AND ALCOHOL METABOLISM IN MICE FOLLOWING LONG-TERM ALCOHOL CONSUMPTION
- (2011) CHUNG-HSI CHOU et al. JOURNAL OF FOOD BIOCHEMISTRY
- From the metabolic syndrome to NAFLD or vice versa?
- (2010) Ester Vanni et al. DIGESTIVE AND LIVER DISEASE
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
- (2008) Mesut Ozkaya et al. FERTILITY AND STERILITY
- In vitroantioxidant activity of silymarin
- (2008) Ekrem KÖksal et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now